Felipe M. Jaworski
Buenos Aires, C C1428EGA, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome.
Journal: Journal for immunotherapy of cancer
Published: November 18, 2020
Heme Oxygenase 1 Impairs Glucocorticoid Receptor Activity in Prostate Cancer.
Journal: International journal of molecular sciences
Published: January 30, 2019
Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis.
Journal: Cell death & disease
Published: September 25, 2017
High RAC3 expression levels are required for induction and maintaining of cancer cell stemness.
Journal: Oncotarget
Published: September 12, 2017
In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 12, 2017
Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.
Journal: Glycobiology
Published: June 19, 2014
Galectins: major signaling modulators inside and outside the cell.
Journal: Current molecular medicine
Published: July 18, 2013
Delineating the "galectin signature" of the tumor microenvironment.
Journal: Oncoimmunology
Published: December 31, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026